Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis.

Ten hypothyroid patients with Hashimoto's thyroiditis were treated with methimazole 30 mg in addition to thyroxine 0.15 mg daily. Another 10 hypothyroid patients with Hashimoto's thyroiditis were given thyroxine 0.15 mg alone. After 22 weeks of treatment significant decreases in thyroid microsomal autoantibody titres were observed in both groups (p less than 0.01). There was no difference in the mean change in titre between the two groups. When the patients treated with methimazole were subsequently given thyroxine 0.15 mg alone for a further 22 weeks no additional change in titre was observed. The data suggest that thyroxine, by normalising serum thyroid stimulating hormone concentrations, may reduce the autoantigenic properties of the thyrocytes with a subsequent decrease in autoantibody titres.

[1]  A. Williams.  Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. , 1984, British medical journal.

[2]  P. Kendall‐Taylor.  Are antithyroid drugs immunosuppressive? , 1984, British medical journal.

[3]  U. Forsum,et al.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. , 1984, Clinical and experimental immunology.

[4]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[5]  R. Jansson,et al.  Comparative bioavailability of carbimazole and methimazole. , 1983, International journal of clinical pharmacology, therapy, and toxicology.

[6]  N. Okabe,et al.  Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole. , 1983, Journal of clinical & laboratory immunology.

[7]  R. Jansson,et al.  Intrathyroidal concentrations of methimazole in patients with Graves' disease. , 1983, The Journal of clinical endocrinology and metabolism.

[8]  A. McGregor,et al.  Methimazole inhibits thyroid autoantibody production by an action on accessory cells. , 1983, Clinical immunology and immunopathology.

[9]  J. Lazarus,et al.  The accumulation of [35S]methimazole by human and rat lymphocytes. , 1983, Acta endocrinologica.

[10]  T. Davies,et al.  Inhibition of immunoglobulin-secreting cells by antithyroid drugs. , 1981, The Journal of clinical endocrinology and metabolism.

[11]  F. Karlsson,et al.  THYROID STIMULATING ANTIBODIES (TSAb) IN PATIENTS WITH GRAVES' DISEASE UNDERGOING ANTITHYROID DRUG TREATMENT: INDICATORS OF ACTIVITY OF DISEASE , 1981, Clinical endocrinology.

[12]  B. Smith,et al.  Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. , 1980, British medical journal.

[13]  A. McGregor,et al.  Carbimazole and the autoimmune response in Graves' disease. , 1980, The New England journal of medicine.

[14]  A. Forsgren,et al.  Effects of antithyroid drugs on lymphocyte function in vitro. , 1980, The Journal of clinical endocrinology and metabolism.

[15]  C. Teng,et al.  Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. , 1980, The Journal of clinical endocrinology and metabolism.

[16]  K. Hashizume,et al.  Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. , 1979, The Journal of clinical endocrinology and metabolism.

[17]  A. Pinchera,et al.  Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. , 1969, The Journal of clinical endocrinology and metabolism.